Bioanalytical

A two-day in person event packed with leading speakers, research and cutting-edge presentations on RNA-based therapeutic medicines, formulation and delivery of mRNA, RNAi and siRNA therapeutics. Experience case studies, technical presentations, and interactive discussions on the latest breakthroughs in this promising area of drug development.

The Scientific Program features a diverse range of scientific sessions organized into two concurrent themed tracks covering issues such as Novel In Vitro and In Silico Assays to Predict Human Safety, In Vivo and Ex vivo Case Studies For Safety, Debate on the “Value” of Primary Tissue and In Vivo Studies and are disease Models Relevant in Safety Pharmacology, Macro Molecules Science: Antibodies, Oligo, and Peptides, Translation Beyond FIH Exposure Response Models, Macro Molecules Science: Gene therapy, Cell Therapy, mRNA and PROTAC, Derisking and Risk Mitigation Strategies, Clinical Cardiology, and much more! This will ensure attendees can stay abreast of new content and developments in key areas of interest. 

A dedicated 2-day hybrid meeting with a focus on paving the road to laboratory
digitalisation through automation, robotics and cutting-edge informatics tools & technologies. 3 interactive tracks aiding the acceleration of laboratory digitalisation within the pharmaceutical industry: from setting up the labs of the future through to the application of automation and robotics & the implementation of state of-the-art IT tools and technologies.

An intensive 2-day in person meeting that delves into the latest in vaccine research, platform technologies, analytics and vaccine development & a meeting place for experts working within cutting-edge vaccine research & development. From new and exciting to the latest in products & services, our event will bring together over 200 leading companies for engaging discussions, knowledge sharing and focused networking.

The Next Generation Dx Summit is the nexus for key opinion leaders across the world to share recent progress in diagnostic advancement and technology innovation. The event provides a valuable window on how point-of-care, infectious disease, liquid biopsy and companion diagnostics are changing the standard of care.

Join thousands of international thought leaders to discuss the latest research, technologies, innovation and business models in implementing precision medicine, biomarkers and companion diagnostics, genomic medicine, and precision health; innovation and market access strategies for at-home diagnostics, point-of-care testing and molecular diagnostics for infectious diseases; liquid biopsy and advanced diagnostics for precision oncology, including Multi-Cancer Early Detection and Minimal Residual Disease testing; and emerging technologies for spatial biology and single-cell multiomics.